Cholangiocarcinoma Foundation logo

ICRN Membership

CHOLANGIOCARCINOMA

The International Cholangiocarcinoma Research Network (ICRN) is a global collaboration of research groups from renowned institutions who are working in concert to improve knowledge about cholangiocarcinoma etiology, prevention, early detection, treatment, and prognosis. The network is comprised of highly talented individuals from a spectrum of disciplines, perspectives, and research methods who share a passion to make significant scientific advances to improve outcomes for patients with cholangiocarcinoma.

Mitesh Borad, MD Assistant Professor of Medicine and Director of Phase I Drug Development at Mayo Clinic in Arizona, ICRN Chair; and Nilofer Azad, MD Associate Professor of Oncology at Johns Hopkins, ICRN Vice Chair, invite all professionals who’s clinical and research interests are focused on cholangiocarcinoma to join the ICRN.

Individual ICRN membership is free and open to properly credentialed scientists and researchers (not employed with industry) whose clinical/research interests are focused on cholangiocarcinoma.

Membership
Benefits

  • Convene regularly with a global network of renowned cholangiocarcinoma clinicians and researchers and join relevant Interest Groups
  • Collaborate with other members from worldwide institutions on multi-center clinical trials and other projects
  • Access to funding streams facilitated by CCF
  • Access to the CCF data resources, including the Cholangiocarcinoma Foundation Patient Registry (powered by Citizen Health) and real-world claims data powered by Komodo Health
  • Receive regular updates by the ICRN newsletter
  • If you are a young investigator [within 3 years of faculty appointment], access to mentorship and career development opportunities
  • Ability to post academic vacancies in your institution via the newsletter 
  • Opportunities for leadership roles within the individual committees 
  • Contribute to industry strategy through working with CCF Industry Forums

Membership
Requirements

  • Actively participate in ICRN meetings and initiatives
  • Acknowledge CCF in publications stemming from ICRN work
  • You will be required to sign a Confidentiality Disclosure Agreement (CDA) with CCF/ICRN
  • We welcome working with Industry partners, but this will be through the Industry Council and not ICRN
Join Here

For more information, contact research@curecca.org